Bluetooth in Connected Medical Devices: System-Level Architectural Choices
TL;DR
- BLE is the first wireless link in most remote monitoring architectures, but selecting it involves firmware, SOUP management, and regulatory documentation, not just hardware.
- SoC vs. NCP is a foundational architectural choice with direct implications for software coupling, regression risk, and traceability.
- Security architecture must be established at the start of development; late integration consistently expands validation scope and regulatory exposure.
- Hardware strategy, including module selection and antenna design, affects RF certification timelines, battery life, and long-term maintainability.
- Chipset and platform selection should be evaluated against a 10 to 20 year device lifespan. Silicon obsolescence cycles are shorter, and vendor lifecycle commitments require explicit assessment.
Modern medical devices are no longer confined to hospital settings. Wearable cardiac monitors, home respiratory systems, and remote patient monitoring devices now operate within broader digital health networks. Patient data is collected in the home and transmitted to clinicians, healthcare providers, or cloud-based analytics platforms.
Bluetooth Low Energy (BLE) is commonly used to enable this communication because it offers low power consumption, global interoperability, and native support across smartphones and tablets. It is particularly well-suited for close-proximity, body-worn applications where energy efficiency and co-existence with consumer devices are essential while staying within RF limits for close-proximity to the body.
However, selecting Bluetooth for a medical device is not the same as selecting Bluetooth for a consumer product. In regulated environments, connectivity choices shape software lifecycle documentation, risk management, cybersecurity design, and long-term maintainability, including how third-party components are evaluated and maintained.
BLE in the Remote Monitoring Ecosystem
In a typical remote monitoring setup:
- A wearable or portable device collects physiological data
- BLE connects the device to a smartphone, tablet, or gateway
- The gateway securely uploads data to backend infrastructure or a cloud platform
- Higher-performance systems perform analytics and, increasingly, AI-driven processing that may not be feasible on resource-constrained edge devices
- Clinicians and caregivers access dashboards, alerts, and decision-support outputs
While this flow appears straightforward, each layer introduces architectural and regulatory considerations.
Firmware and middleware components involved in this flow, such as BLE stacks or RTOS modules, are often considered third-party software of unknown provenance (SOUP). In regulated devices, these components require formal risk assessment, traceability, verification planning, and lifecycle maintenance under standards such as ISO 14971 and IEC 62304. Wireless decisions therefore influence documentation scope and validation effort throughout the product lifecycle.
Architectural Choices: SoC vs. NCP
One of the first major choices is how BLE fits into the system architecture.
In a System-on-Chip (SoC) approach, the BLE stack and application firmware share the same processor. This can simplify hardware design but increases the interdependence between wireless and application functionalities.
In a Network Co-Processor (NCP) approach, the BLE stack operates on a dedicated wireless device, while the host manages application logic. This separation:
- Reduces firmware coupling
- Mitigates the regression impact during stack updates
- Improves traceability within regulated software processes
- Supports scalable product families
However, it introduces additional interface management and system-level integration complexity.
These architectural choices also determine how third-party software (SOUP) is incorporated into the device and managed throughout the product lifecycle. The appropriate choice therefore depends on product complexity, lifecycle expectations, software update strategy, and risk tolerance.
Security Architecture Must Be Established Early
BLE includes encryption mechanisms, but achieving a secure implementation requires more than enabling pairing.
Medical device teams must consider:
- Strategies for secure pairing and bonding
- Encoding and encryption of protected health information (PHI) in transit
- Secure management and storage of cryptographic keys
- Secure boot processes and firmware authenticity
- Validation of over-the-air (OTA) updates
Given that device firmware often relies on SOUP components such as BLE stacks or RTOS modules, these must be thoroughly evaluated during risk management and validation planning from the outset. Establishing security architecture late in development often expands both validation scope and regulatory exposure. In regulated settings, cybersecurity activities must integrate and align with risk management processes early in the product lifecycle.
Hardware Strategy: Integration and Antenna Considerations
Module vs PCB-Level Integration
Hardware selection affects development timelines and regulatory responsibilities. Using pre-certified BLE modules lowers RF design risk and speeds up submission timelines. Integrating the BLE SoC and RF components directly onto the product PCB can offer cost and size advantages at scale, but requires more rigorous RF validation and introduces additional certification complexity. For early-stage or lower-volume medical devices, minimizing RF uncertainty may outweigh incremental cost savings.
Antenna Strategy
Beyond integration level, antenna strategy is often another significant architectural requirement, especially in body-worn medical devices. Options include:
- Integrated PCB antennas
- Chip antennas
- External antennas
- Body-matched or enclosure-optimized antenna designs
Antenna selection directly affects radiation efficiency, battery life, thermal performance, and regulatory compliance. In wearable systems where the device sits in close proximity to the body, these factors interact — a choice that optimizes signal strength may compromise battery performance, and vice versa. Hardware strategy therefore reinforces the need for system-level evaluation.
Power and Throughput Choices Are Architecture Decisions
Remote battery powered monitoring devices typically operate under strict energy constraints. Connectivity parameters affect this are:
- Battery size and device form factor
- Recharge frequency
- Thermal behavior
- Long-term reliability
- Connection and transmission intervals
With AI-driven analytics demands surfacing rapidly with the AI-era, increasing demand for continuous or higher-resolution data introduces competing requirements.
Thus, balancing connection intervals, data packaging efficiency, and transmission strategy is not solely a firmware choice; it affects clinical usability and patient adherence. Connectivity parameters therefore become part of overall product architecture rather than isolated configuration choices.
Chipset Selection Is a Long-Term Platform Commitment
Selecting a BLE chipset means selecting an ecosystem. SDK maturity, documentation quality, OTA update support, and silicon roadmaps all influence:
- Maintainability (or disposability)
- Verification scope
- Security update pathways
- Product lifespan
- Supplier lifecycle and support
A prototype can succeed on many platforms. A regulated product line requires long-term architectural thinking and alignment with documentation processes, risk management, and lifecycle obligations.hoices.
Treat Connectivity as an Architectural Requirement from Day One
A common pitfall is selecting BLE based on early prototyping convenience, only to encounter coupling, obsolescence, and validation complexity later.
Connectivity choices should be driven by system-level requirements:
- Expected product lifespan
- Cybersecurity posture and risk
- Regulatory documentation and compliance strategy
- Future product scalability
While medical devices target operational lifespans of roughly 10 to 20 years, commercial silicon may follow shorter release and obsolescence cycles. Longevity and support policies are published by major silicon vendors on their websites. This mismatch requires early evaluation of supplier longevity, migration pathways, and long-term firmware maintenance strategy. Evaluating vendor lifecycle commitments and silicon availability policies should therefore be an explicit part of platform selection.
In regulated systems, connectivity is not an accessory. It becomes part of the safety case and must be treated accordingly.
StarFish Medical evaluates BLE platforms and architectural approaches across connected medical device programs, with the goal of ensuring connectivity strategy aligns with long-term regulatory, cybersecurity, and lifecycle requirements. Selecting Bluetooth for a medical device is not simply a component choice; it is an architectural commitment that influences security design, risk ownership, third-party software integration, regulatory compliance, and in-market maintenance obligations throughout the product’s lifecycle.
A thoughtful BLE strategy enables scalable connectivity without introducing avoidable compliance or maintenance challenges. When the right architecture and lifecycle approach are established early, remote monitoring can shift its focus from troubleshooting connectivity to patient recovery, health outcomes, and clinical impact.
Charu Pande is a Firmware Engineer at StarFish Medical.
Images: Adobe Stock
Related Resources
Medical device teams developing embedded and cross-platform GUIs can accelerate delivery without compromising usability or validation by choosing the right framework early and designing for performance, portability, and maintainability.
Many developers have tried using AI to generate code, often called “Vibe Coding”. Sometimes, the results are nothing short of amazing. Other times, the results are mixed, or worse.
FDA cybersecurity requirements for medical devices which are considered “cyber devices”, including US government definition.
FDA DHT Clinical Investigations examines the latest FDA draft guidance on Digital Health Technology for remote data acquisition in clinical investigations.